切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - c-RET - CREBBP - adrenergic receptor - Histone Demethylases

10 件产品

每页
清除全部
  1. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: 新型LSD1拮抗剂
      ≥19.45 mg/mL
      insoluble in H2O
  2. G-749
    A8889 G-749
    Target: Aurora Kinases|FLT3|c-RET
    Summary: FLT3抑制剂
      ≥26.05 mg/mL
      insoluble in H2O
  3. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  4. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  5. SGC-CBP30
    A4491 SGC-CBP30
     2 Citation
    Target: CREBBP|EP300
    Summary: CREBBP/EP300 bromodomain抑制剂
      ≥20.05 mg/mL
      ≥4.67 mg/mL
  6. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain抑制剂
      ≥49.6 mg/mL
      insoluble in H2O
  7. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    中文名: 瑞戈非尼盐酸盐
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: 酪氨酸激酶抑制剂
      ≥25.95 mg/mL
      insoluble in H2O
  8. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  9. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  10. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    中文名: 费德拉替尼
    Target: FLT3|JAK|c-RET
    Summary: JAK-2抑制剂
      ≥26.23 mg/mL
      insoluble in H2O

10 件产品

每页